Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q64110036> ?p ?o ?g. }

Showing items 1 to 100 of ±110 with 100 items per page.

Q64110036 description "artículu científicu espublizáu en mayu de 2019" @default.
Q64110036 description "im Mai 2019 veröffentlichter wissenschaftlicher Artikel" @default.
Q64110036 description "scientific article published on 28 May 2019" @default.
Q64110036 description "wetenschappelijk artikel" @default.
Q64110036 description "наукова стаття, опублікована у квітні 2019" @default.
Q64110036 name "Long-term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J-STEP/GLP): a 52-week open-label, multicenter, post-mar" @default.
Q64110036 name "Long-term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J-STEP/GLP): a 52-week open-label, multicenter, post-mar" @default.
Q64110036 type Item @default.
Q64110036 label "Long-term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J-STEP/GLP): a 52-week open-label, multicenter, post-mar" @default.
Q64110036 label "Long-term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J-STEP/GLP): a 52-week open-label, multicenter, post-mar" @default.
Q64110036 prefLabel "Long-term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J-STEP/GLP): a 52-week open-label, multicenter, post-mar" @default.
Q64110036 prefLabel "Long-term safety and efficacy of the sodium glucose cotransporter 2 inhibitor tofogliflozin added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus (J-STEP/GLP): a 52-week open-label, multicenter, post-mar" @default.
Q64110036 P1433 Q64110036-005530B1-1EEB-449D-B2FC-5A1CFF99F372 @default.
Q64110036 P1476 Q64110036-9C08C03D-C15C-4469-BD21-9ABC5BFD117C @default.
Q64110036 P2093 Q64110036-1B474ECC-95B1-4A02-973A-DE00AD88C2FD @default.
Q64110036 P2093 Q64110036-3B01969A-21B3-435E-995F-322A3963B15A @default.
Q64110036 P2093 Q64110036-D6181133-FA0C-4933-A2E2-5D7C15DA1EE7 @default.
Q64110036 P2860 Q64110036-026F776D-AA8A-4163-AA6A-B9EF6A55E918 @default.
Q64110036 P2860 Q64110036-039F7614-086F-4D6F-A5EA-8696C5A7B0E9 @default.
Q64110036 P2860 Q64110036-1095FCF4-1916-4B3B-8D94-E1C60DCB9075 @default.
Q64110036 P2860 Q64110036-305B6F67-4B20-4DCF-94FA-97B959322841 @default.
Q64110036 P2860 Q64110036-3A9EA76D-792E-48C1-9427-06B6EFAD8F07 @default.
Q64110036 P2860 Q64110036-45009272-EDB7-47E1-B790-25BF9191EF0E @default.
Q64110036 P2860 Q64110036-4BC72F5D-4FB1-48EB-AF62-7EA2F839E9ED @default.
Q64110036 P2860 Q64110036-4F4E4F7F-BD4F-4513-9488-9496355B9E69 @default.
Q64110036 P2860 Q64110036-5E2A8824-18FC-4FDE-8DB9-6B736C7E83C2 @default.
Q64110036 P2860 Q64110036-637588E6-BA88-4EB5-9C56-34A6C28AB1D5 @default.
Q64110036 P2860 Q64110036-79203BF8-751A-4E29-B8E8-6F33C937DE7F @default.
Q64110036 P2860 Q64110036-7C1761F1-5BCC-4B08-A908-0941625E64A5 @default.
Q64110036 P2860 Q64110036-8AE9C366-C9C8-4D5C-B144-DD3F62A58537 @default.
Q64110036 P2860 Q64110036-9B0FA72C-86BA-447C-92C7-AC2B6FBA08E7 @default.
Q64110036 P2860 Q64110036-A15F6745-41DD-4DF4-BB69-8C50DC48737F @default.
Q64110036 P2860 Q64110036-A2299D52-7C6E-4C91-B096-5001A4986D7F @default.
Q64110036 P2860 Q64110036-AFF3F6B7-368D-4DBA-9D3D-A2D25E8585C0 @default.
Q64110036 P2860 Q64110036-B3065F09-DA70-43B0-B8D0-20E88C9807E4 @default.
Q64110036 P2860 Q64110036-BADDB447-975C-4EE3-9205-B67331C11A6D @default.
Q64110036 P2860 Q64110036-BCB561A8-F9CA-4899-85EF-D06C1A63D6A2 @default.
Q64110036 P2860 Q64110036-C4C956EF-3AB4-4AB8-9EF8-94011057B546 @default.
Q64110036 P2860 Q64110036-C91DEC6E-9362-4E8E-AC5E-6C6B0B32B324 @default.
Q64110036 P2860 Q64110036-DEE40FF7-9F33-4BA7-A0F9-0905AD9530F6 @default.
Q64110036 P2860 Q64110036-E81D3AEE-C34C-48D0-BB78-DDFEA15DFD39 @default.
Q64110036 P2860 Q64110036-EA96EAFD-36A0-484B-B30F-7D0C2A0609C2 @default.
Q64110036 P2860 Q64110036-ED9B26E8-1BC0-45C2-8CAB-07926F2B158C @default.
Q64110036 P2860 Q64110036-FC5CC297-5E99-4D6A-A400-06619BD6DD22 @default.
Q64110036 P2860 Q64110036-FE143F04-7BD5-42FF-A457-D7F1BC495D4D @default.
Q64110036 P304 Q64110036-805B712B-B470-43B4-B426-C23DADEEEC82 @default.
Q64110036 P31 Q64110036-F1B67E27-9DE6-4BBC-8D4E-A666C272340A @default.
Q64110036 P356 Q64110036-02BD5511-0B6F-459D-A448-5EE1CCA16F8C @default.
Q64110036 P407 Q64110036-B64581BF-C007-4A59-B632-1CA3E6B598A6 @default.
Q64110036 P433 Q64110036-2E59F610-B57D-4949-B89B-3EFBCC576995 @default.
Q64110036 P478 Q64110036-2F34B8A0-2E0E-4AFE-BEDF-842EBD498F43 @default.
Q64110036 P50 Q64110036-2DE461F1-AC9A-436F-99D0-7EA7CCAA04E6 @default.
Q64110036 P50 Q64110036-34896F6C-306F-4E37-AB04-75CE83EF57AF @default.
Q64110036 P50 Q64110036-46D271CC-EDCA-4D9B-9E74-71C3A08A74C9 @default.
Q64110036 P50 Q64110036-7BA27E31-EE88-4019-89C2-9A8842F8E52B @default.
Q64110036 P50 Q64110036-7E7092D4-76C6-47AD-82BD-08E34D09D67D @default.
Q64110036 P577 Q64110036-C649A0FE-54B2-458F-B9B6-F2D4583D1809 @default.
Q64110036 P698 Q64110036-952B3F92-8910-4D49-9F75-977A66E02F9F @default.
Q64110036 P921 Q64110036-7309BDEE-3373-4F79-8B4C-4DCA9B8A2AFC @default.
Q64110036 P932 Q64110036-4909129A-9F72-4BD3-A56C-D6DBF0547C53 @default.
Q64110036 P356 JDI.13066 @default.
Q64110036 P698 31033218 @default.
Q64110036 P1433 Q28207066 @default.
Q64110036 P1476 "Long-term safety and efficacy of the sodium-glucose cotransporter 2 inhibitor, tofogliflozin, added on glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week open-label, multicenter, post-marketing clinical study" @default.
Q64110036 P2093 "Hideki Suganami" @default.
Q64110036 P2093 "Masahiro Tamura" @default.
Q64110036 P2093 "Ryoji Gunji" @default.
Q64110036 P2860 Q26746901 @default.
Q64110036 P2860 Q26799389 @default.
Q64110036 P2860 Q28273497 @default.
Q64110036 P2860 Q33612741 @default.
Q64110036 P2860 Q34293786 @default.
Q64110036 P2860 Q34420901 @default.
Q64110036 P2860 Q36345951 @default.
Q64110036 P2860 Q37141727 @default.
Q64110036 P2860 Q37711170 @default.
Q64110036 P2860 Q37737187 @default.
Q64110036 P2860 Q37848043 @default.
Q64110036 P2860 Q37940036 @default.
Q64110036 P2860 Q38762377 @default.
Q64110036 P2860 Q38912082 @default.
Q64110036 P2860 Q39368551 @default.
Q64110036 P2860 Q39430493 @default.
Q64110036 P2860 Q40363925 @default.
Q64110036 P2860 Q41184651 @default.
Q64110036 P2860 Q42082791 @default.
Q64110036 P2860 Q42658161 @default.
Q64110036 P2860 Q46110493 @default.
Q64110036 P2860 Q47374718 @default.
Q64110036 P2860 Q50957907 @default.
Q64110036 P2860 Q53094851 @default.
Q64110036 P2860 Q53551539 @default.
Q64110036 P2860 Q83629703 @default.
Q64110036 P2860 Q85985011 @default.
Q64110036 P2860 Q87261695 @default.
Q64110036 P304 "1518-1526" @default.
Q64110036 P31 Q13442814 @default.
Q64110036 P356 "10.1111/JDI.13066" @default.
Q64110036 P407 Q1860 @default.
Q64110036 P433 "6" @default.